Comprehensive management of haemophilia.
Haemophilia is a congenital, life-long disorder that may cause major disabilities. The goal of comprehensive care is to prevent problems when possible, to treat early in order to minimize morbidity, and to restore function to disabled patients. The co-ordinated efforts of many experts are needed for success.
D015119:Aminocaproic Acid / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001168:Arthritis / Q000517:prevention & control; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D001803:Blood Transfusion; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D003729:Dental Care; D004967:Estrogens / Q000627:therapeutic use; D005164:Factor IX / Q000627:therapeutic use; D015949:Factor IXa; D005169:Factor VIII / Q000627:therapeutic use; D006467:Hemophilia A / Q000628:therapy*; D002836:Hemophilia B / Q000628:therapy; D006470:Hemorrhage / Q000628:therapy; D006801:Humans; D009910:Oral Hygiene; D010949:Plasma; D011374:Progesterone / Q000627:therapeutic use; D012646:Self Administration; D013514:Surgical Procedures, Operative; D013552:Swine; D013585:Synovitis / Q000517:prevention & control
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001779:Blood Coagulation Factors; D004967:Estrogens; C025667:prothrombin complex concentrates; D011374:Progesterone; D005169:Factor VIII; D005164:Factor IX; D015949:Factor IXa; D003894:Deamino Arginine Vasopressin; D015119:Aminocaproic Acid